|
Reference | Year | Model | ADSC origin | ADSC surface markers | BCC line | Ratio BCC/ADSC | Effects on BCC/BC |
|
Eterno et al. [60] | 2014 | Mouse | Human lipoaspirates and breast whole fat (normal versus cancer-affected) | CD44+CD90+CD117+ CD133+ CD34lowCD45− | MCF-7, MDA-MB-231, primary BCCs | 2 : 1 | No changes in MCF-7 MDA-MB-231 growth and migration↑ EMT↑ Paracrine, IL-8↑, IL-6↓ |
|
Rowan et al. [71] | 2014 | Mouse | Human lipoaspirates (abdominal) | CD29+CD34+CD73+ CD90+CD105+ CD44lowCD45low | BT-474, MCF-7, MDA-MB-231 | 1 : 1 | Tumor growth↔ Migration and metastasis↑ EMT induction |
|
Orecchioni et al. [41] | 2013 | Mouse | Human lipoaspirates | CD31+CD34+CCRL2+ CD13−CD45− (EPC) and CD13+CD34+ CD140b+ CD31−CD45− (ADSC) | HCC1937, MDA-MB-436, ZR75-1 | 5 : 1 | Tumor growth↑ Metastatic spread↑ EMT↑ Effect of ADSCs > EPCs |
|
Chandler et al. [36] | 2012 | Mouse | Human lipoaspirates | CD13+CD29+CD44+ CD73+CD90+CD105+ CD166+ CD14−CD31−CD45− | MCF-7, MDA-MB-231 | 1 : 1 | Tumor growth↑ Angiogenesis↑ Bidirectional signaling ADSCs differentiate to CAFs |
|
Zhang et al. [22] | 2012 | Mouse | Murine (endogenous) | CD34+ CD31−CD45− | E0771, MDA-MB-231 | n.s. | Circulating ADSCs↑ in cancer ADSCs incorporate into tumor vasculature (as pericytes) |
|
Zhao et al. [74] | 2012 | Mouse | Human breast (normal) | CD29+CD73+CD90+ CD105+ CD14−CD31−CD45− | HMT-3522 S3 (preinvasive), HMT-3522 T4-2 (invasive), MDA-MB-231 | 1 : 1, 3 : 2 | Tumor growth↑ Tumor invasiveness↑ Angiogenesis↔ No effect on preinvasive BCCs |
|
Dirat et al. [39] | 2011 | Mouse | Murine 3T3 adipocytes | — | 4T1, 67NR, (murine) ZR 75.1, SUM159PT | n.s. | Metastatic spread↑ IL-6-dependent |
|
Martin-Padura et al. [43] |
2012 | Mouse | Murine whole fat | CD34+ CD45− | HCC1937, MDA-MB-436 | 5 : 1 | Tumor growth↑ Metastatic spread↑ Angiogenesis↑ |
|
Zimmerlin et al. [5] | 2011 | Mouse | Human abdominal whole fat | CD34+CD44+CD73+ CD90+CD105+CD146+ CD45−CD31− | Human MPE | n.s. | Tumor growth↑ (active cells, but not resting cells) |
|
Muehlberg et al. [30] | 2009 | Mouse | Murine whole fat | CD44+CD90+CD105+ CD11b−CD14−CD34− CD45−HLA-DR− | 4T1 (murine), MDA-MB-231 | 1 : 10 | Tumor growth↑ Metastatic spread↑ Paracrine through SDF-1 ADSCs home to tumor and differentiate to ECs |
|
Sun et al. [49] | 2009 | Mouse | Human breast whole fat | n.s. | MDA-MB-231 | 2 : 1 | Tumor growth↓ Metastatic spread↓ No early carcinogenesis improvement |
|
Walter et al. [42] | 2009 | Mouse | Human breast whole fat and abdominal lipoaspirates | n.s. | MCF-7, MDA-MB-231 | 1 : 1 | Tumor migration and invasiveness↑ IL-6-dependent |
|
Zhang et al. [89] | 2009 | Mouse | Murine whole fat (obese mice) | CD34+ CD31−CD45− (ADSC) and CD31+CD34+ CD45− (EPC) | 4T1, EF43.fgf4 (murine), MDA-MB-231 | n.s. | Tumor growth↑ ADSCs home to tumor (perivascular space) |
|